Dyadic International Inc
DYAI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213809
In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Dyadic International Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 32 | 32 | 0 |
| Shares | 4.50M | 4.50M | −1.09K (0.0%) |
| Value | $8.68M | $8.63M | −$47.1K (−0.5%) |
New holders (3)
Institutions that held Dyadic International Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 25,786 | $49.5K | 0.00% |
| Atria Wealth Solutions, Inc. | 24,136 | $46.3K | 0.00% |
| Renaissance Technologies LLC | 11,000 | $21.0K | 0.00% |
Sold out (3)
Institutions that held Dyadic International Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 16,500 | $31.8K |
| Sabal Trust CO | 11,111 | $21.4K |
| UBS Group AG | 3,112 | $6.01K |